The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile (Q35506849)
Jump to navigation
Jump to search
scientific article published on 19 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile |
scientific article published on 19 April 2011 |
Statements
1 reference
The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile (English)
1 reference
Christopher A Eide
1 reference
Lauren T Adrian
1 reference
Mary Mac Partlin
1 reference
David J Anderson
1 reference
Scott C Wise
1 reference
Bryan D Smith
1 reference
Peter A Petillo
1 reference
Daniel L Flynn
1 reference
Michael W N Deininger
1 reference
Thomas O'Hare
1 reference
19 April 2011
1 reference
1 reference
Identifiers
1 reference